Clinical Trials Browser

Phase 1/2 × INDUSTRY × enzastaurin × Clear all

NCT00452413 2021-05-13

A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer

Phase 1/2 Completed

65 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00402116 2020-08-06

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Phase 1/2 Completed

72 enrolled 19 charts

Glioblastoma, Gliosarcoma